SWEDISH ORPHAN/S (OTCMKTS:SWTUY) Trading Down 1.2% – Here’s Why

Shares of SWEDISH ORPHAN/S (OTCMKTS:SWTUYGet Free Report) traded down 1.2% during mid-day trading on Friday . The company traded as low as $24.38 and last traded at $24.38. 200 shares were traded during mid-day trading, a decline of 88% from the average session volume of 1,665 shares. The stock had previously closed at $24.67.

SWEDISH ORPHAN/S Trading Down 1.2%

The business’s fifty day simple moving average is $24.38 and its 200 day simple moving average is $24.38. The stock has a market cap of $6.64 billion, a price-to-earnings ratio of 48.76, a price-to-earnings-growth ratio of 1.30 and a beta of 1.81.

About SWEDISH ORPHAN/S

(Get Free Report)

Swedish Orphan Biovitrum AB (publ), an integrated biotechnology company, researches, develops, manufactures, and sells pharmaceuticals in the therapeutic areas of haemophilia, inflammation, and genetic and lysosomal diseases. The company offers Elocta to treat haemophilia A; and Alprolix to treat haemophilia B.

Featured Articles

Receive News & Ratings for SWEDISH ORPHAN/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SWEDISH ORPHAN/S and related companies with MarketBeat.com's FREE daily email newsletter.